[Corrigendum] Antitumor activity of gambogic acid on NCI‑H1993 xenografts via MET signaling pathway downregulation

Li,Donglei; Yang,Huiwei; Li,Runpu; Wang,Yanli; Wang,Weijun; Li,Dongjie; Ma,Shaolin; Zhang,Xuyu

doi:10.3892/ol.2021.12477

March-2021 Volume 21 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-2021 Volume 21 Issue 3

Full Size Image

Correction Open Access

[Corrigendum] Antitumor activity of gambogic acid on NCI‑H1993 xenografts via MET signaling pathway downregulation

Authors:
- Donglei Li
- Huiwei Yang
- Runpu Li
- Yanli Wang
- Weijun Wang
- Dongjie Li
- Shaolin Ma
- Xuyu Zhang
View Affiliations / Copyright

Affiliations: Oncology Department, Baoding Second Central Hospital of Oncology, Zhuozhou, Hebei 072750, P.R. China

Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 216
|
Published online on: January 20, 2021

https://doi.org/10.3892/ol.2021.12477
Expand metrics +

Article

Oncol Lett 10: [Related article:] 2802-2806, 2015; DOI: 10.3892/ol.2015.3719

Subsequently to the publication of the above paper, an interested reader drew to the authors’ attention that the panels shown in Fig. 3A showed some unexpected similarities when comparing the different panels.

Figure 3.

GA inhibits the expression of Ki-67 in the NCI-H1993 ×enograft model. The NCI-H1993 ×enograft model was treated with various doses of GA, vehicle or positive control for 2 h on day 21 of the efficacy study. (A) Representative images of Ki-67 staining. (B) Quantification of Ki-67 positive area (%). Values are expressed as the mean ± standard deviation, n=10. *P<0.05 vs. vehicle group; **P<0.01 vs. vehicle group. GA, gambogic acid; i.p., intraperitoneal; i.v., intravenous.

The authors have re-examined their data and realized that Fig. 3A was assembled incorrectly as certain of the data panels had been mislabelled; however, the authors were able to reassemble this Figure based on the results they obtained from one of their repeated experiments, and the revised version of Fig. 3 is shown below. The authors regret the errors that were made during the preparation of the Figure, although they were able to confirm that these errors did not seriously affect the conclusions reported in the paper. The authors are grateful to the editor of Oncology Letters for allowing them the opportunity to publish a Corrigendum, and all the authors agree to this Corrigendum. Furthermore, they apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Antitumor activity of gambogic acid on NCI‑H1993 xenografts via MET signaling pathway downregulation

This article is mentioned in:

Article

Figure 3.

Related Articles